Literature DB >> 32745173

The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening.

Mark Schiffman1, Nicolas Wentzensen1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32745173      PMCID： PMC7936058          DOI： 10.1093/jnci/djaa106

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

1.  A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.

Authors:  Mark Schiffman; Andrew G Glass; Nicolas Wentzensen; Brenda B Rush; Philip E Castle; David R Scott; Julie Buckland; Mark E Sherman; Greg Rydzak; Peter Kirk; Attila T Lorincz; Sholom Wacholder; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

2.  Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.

Authors:  Nicole J Polman; Renée M F Ebisch; Daniëlle A M Heideman; Willem J G Melchers; Ruud L M Bekkers; Anco C Molijn; Chris J L M Meijer; Wim G V Quint; Peter J F Snijders; Leon F A G Massuger; Folkert J van Kemenade; Johannes Berkhof
Journal:  Lancet Oncol       Date:  2019-01-15       Impact factor: 41.316

3.  Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer.

Authors:  Hui-Chi Chen; Mark Schiffman; Ching-Yu Lin; Mei-Hung Pan; San-Lin You; Li-Chung Chuang; Chang-Yao Hsieh; Kai-Li Liaw; Ann W Hsing; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2011-09-06       Impact factor: 13.506

Review 4.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

5.  False positive cervical HPV screening test results.

Authors:  Mark Schiffman; Silvia de Sanjose
Journal:  Papillomavirus Res       Date:  2019-04-25

6.  Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.

Authors:  Nicolas Wentzensen; Megan A Clarke; Renee Bremer; Nancy Poitras; Diane Tokugawa; Patricia E Goldhoff; Philip E Castle; Mark Schiffman; Julie D Kingery; Kiranjit K Grewal; Alex Locke; Walter Kinney; Thomas S Lorey
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

7.  A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.

Authors:  Maria Demarco; Noorie Hyun; Olivia Carter-Pokras; Tina R Raine-Bennett; Li Cheung; Xiaojian Chen; Anne Hammer; Nicole Campos; Walter Kinney; Julia C Gage; Brian Befano; Rebecca B Perkins; Xin He; Cher Dallal; Jie Chen; Nancy Poitras; Marie-Helene Mayrand; Francois Coutlee; Robert D Burk; Thomas Lorey; Philip E Castle; Nicolas Wentzensen; Mark Schiffman
Journal:  EClinicalMedicine       Date:  2020-04-25

8.  Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.

Authors:  Thomas Iftner; Klaus-Joachim Neis; Alejandra Castanon; Rebecca Landy; Barbara Holz; Astrid Woll-Herrmann; Angelika Iftner; Annette Staebler; Diethelm Wallwiener; Claus Hann von Weyhern; Felix Neis; Juliane Haedicke-Jarboui; Peter Martus; Sara Brucker; Melanie Henes; Peter Sasieni
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

9.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321

10.  Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Didem Egemen; Li C Cheung; Xiaojian Chen; Maria Demarco; Rebecca B Perkins; Walter Kinney; Nancy Poitras; Brian Befano; Alexander Locke; Richard S Guido; Amy L Wiser; Julia C Gage; Hormuzd A Katki; Nicolas Wentzensen; Philip E Castle; Mark Schiffman; Thomas S Lorey
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842
View more
  1 in total

Review 1.  Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination.

Authors:  Flávia M Corrêa; Arn Migowski; Liz M de Almeida; Marcelo A Soares
Journal:  Front Med (Lausanne)       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.